NIC4 Inc., a division of Network Innovations, Inc. specializing in the development and delivery of turnkey satellite communication solutions, has been awarded a commercial...
Accelerate Diagnostics, Inc. an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced commercialization of...
Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced the appointment of Laurie Stelzer as the Company's Chief Financial Officer (CFO) effective May 16,...
The U.S. Food and Drug Administration is announcing important updates on its ongoing work to increase the supply and availability of infant formula in...
BenevolentAI, a leading clinical-stage AI-enabled drug discovery company, announces that AstraZeneca has selected an additional novel target for idiopathic pulmonary fibrosis (IPF) for its...
